ORGO organogenesis.com: Enterprise Value-to-Revenue Multiple

organogenesis.com (ORGO) - corporate logo

Organogenesis Holdings (ORGO) margins depend on Medicare reimbursement policies and FDA requirements. The EV/Sales trajectory clearly demonstrates financial stability, with 819.40 serving as the current value of the metric. Organogenesis Holdings generates revenue from biomaterials for tissue regeneration and wound healing. However, regulatory pressure on the cost of skin substitutes poses serious threats to distribution channels.

EV/Sales Multiple: Organogenesis (ORGO) for 11/23/2025 - 11/20/2026

organogenesis.com - analytical breakdowns and key metrics (ORGO)

- share price and consensus valuation forecast:
- company stock capitalization data:
- cash and cash flow indicators:
Initial company analysis:ORGO (Organogenesis Holdings)
Finished products of Organogenesis Holdings

Long-term investing requires strict control over overpayment relative to an asset's fundamental value. Organogenesis Holdings (ORGO) leadership in regenerative medicine and strong pricing power enable the company to generate a stable cash flow. The EV-to-annual revenue multiple on the GURU.Markets platform compares the total business value to its revenues, excluding the impact of debt load. A decrease in this metric signals an undervaluation of high-quality bioengineered products. This daily price action determines the balance between the risk of stagnation and the potential for share price growth.

Competitor analysis for Organogenesis Holdings

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|DaVita Inc. - Company Value to Revenue Ratio|Enterprise Value-to-Revenue Ratio RadNet Corp RDNT|EV/Sales Multiple Option Care OPCH|Surgery Partners Inc - EV/Sales Multiple|PINC (Premier Corp) - Company Value to Revenue Ratio|nationalvision.com (EYE) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Progyny|Company Value to Revenue ARDT|EV/Sales Multiple Select Medical Corporation|Company Value to Revenue ASTH (Astrana Health)|Company Value to Revenue Pediatrix MD|U.S. Physical Therapy - Company Value to Revenue|Business Value to Revenue PNTG|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple